2005
DOI: 10.1016/j.pnpbp.2005.03.014
|View full text |Cite
|
Sign up to set email alerts
|

The combined dexamethasone/CRH test as a potential surrogate marker in depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
140
1
2

Year Published

2006
2006
2016
2016

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 246 publications
(146 citation statements)
references
References 60 publications
3
140
1
2
Order By: Relevance
“…Studies reported nonsuppression rates of 27-37% (Avery et al, 1985;Schweizer et al, 1986;Tiller et al, 1988) but failed to show an association with GAD symptoms. Furthermore, more recently the sensitivity of the DST has been brought to question (Heuser et al, 1994;Ising et al, 2005;Watson et al, 2006). Thus, due to methodological limitations at the time these studies were performed we currently have a limited understanding of HPA axis function in GAD.…”
Section: Introductionmentioning
confidence: 99%
“…Studies reported nonsuppression rates of 27-37% (Avery et al, 1985;Schweizer et al, 1986;Tiller et al, 1988) but failed to show an association with GAD symptoms. Furthermore, more recently the sensitivity of the DST has been brought to question (Heuser et al, 1994;Ising et al, 2005;Watson et al, 2006). Thus, due to methodological limitations at the time these studies were performed we currently have a limited understanding of HPA axis function in GAD.…”
Section: Introductionmentioning
confidence: 99%
“…This is of interest since chronically stressful situations can be a risk-factor for the onset of major depression (Holsboer, 2000;Brown et al, 2004;Nemeroff and Vale, 2005;Berton and Nestler, 2006). Thus, elevated hormone levels are seen prior to any clinical symptoms in high-risk proband (Ising et al, 2005). Also, the normalization of hormone levels upon treatment predicts for relapse probability (Ribeiro et al, 1993;Zobel et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…There are a number of promising vulnerability markers of depression. Biological markers include response to pharmacological challenges such as the dexamethasone/corticotropin releasing hormone (DEX-CRH) test (Ising et al, 2005) and response to acute tryptophan depletion (Moreno, Henninger, McGahuey, & Delgado, 2000). Promising psychological vulnerability markers include cognitive reactivity (Segal, Gemar, & Williams, 1999), rumination (Kuehner & Weber, 1999), and information-processing indices (Elliott, 1998).…”
mentioning
confidence: 99%